×
About 6,838 results

ALLMedicine™ Creatinine Clearance Center

Research & Reviews  2,099 results

Overcoming Vestiges of Structural Racism in Kidney Care and Renal Nutrition and Revisit...
https://doi.org/10.1053/j.jrn.2021.11.001
Journal of Renal Nutrition : the Official Journal of the ... Kalantar-Zadeh K, Norris KC et. al.

Nov 28th, 2021 - Overcoming Vestiges of Structural Racism in Kidney Care and Renal Nutrition and Revisiting Cockcroft-Gault Creatinine Clearance and Its Weight Index.|2021|Kalantar-Zadeh K,Norris KC,Moore LW,|

Evaluation and enhancement of standard equations for renal function estimation in indiv...
https://doi.org/10.1186/s12882-021-02588-4
BMC Nephrology; Brunetti L, Back H et. al.

Nov 24th, 2021 - The primary objective of this study aims to test patient factors, with a focus on cardiometabolic disease, influencing the performance of the Cockcroft-Gault equation in estimating glomerular filtration rate. A cohort study was performed using dat...

Pomegranate extract ameliorates renal ischemia/reperfusion injury in rats via suppressi...
https://doi.org/10.1177/09603271211041998
Human & Experimental Toxicology; Makled MN, El-Awady MS et. al.

Nov 23rd, 2021 - Inflammation and oxidative stress are the major pathways involved in ischemia-reperfusion (I/R)-induced renal injury. This study was designed to evaluate the potential effect of pomegranate against I/R-induced renal injury. I/R injury was induced ...

Renal denervation for resistant hypertension.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607757
The Cochrane Database of Systematic Reviews; Pisano A, Iannone LF et. al.

Nov 23rd, 2021 - Resistant hypertension is highly prevalent among the general hypertensive population and the clinical management of this condition remains problematic. Different approaches, including a more intensified antihypertensive therapy, lifestyle modifica...

see more →

Guidelines  1 results

KDIGO 2012 Clinical Practice Guideline CKD classification rules out creatinine clearanc...
https://doi.org/10.1016/j.clinbiochem.2015.07.030
Clinical Biochemistry; Ognibene A, Grandi G et. al.

Aug 2nd, 2015 - The recent guideline for the evaluation and management of Chronic Kidney Disease recommends assessing GFR employing equations based on serum creatinine; despite this, creatinine clearance 24-hour urine collection is used routinely in many settings...

see more →

Drugs  187 results see all →

Clinicaltrials.gov  156 results

Transcatheter Para-Valvular Leak Closure: An International Prospective Multicentre Registry
https://clinicaltrials.gov/ct2/show/NCT05089136

Nov 19th, 2021 - Prosthetic paravalvular leaks (PVL) are associated with congestive heart failure and haemolysis, for which the standard treatment is open-heart surgery with the attendant risks to the patient. Transcatheter closure has emerged as an alternative. P...

Search for New Methods to Detect Acute Renal Failure
https://clinicaltrials.gov/ct2/show/NCT00026702

Oct 26th, 2021 - The mortality of acute renal failure (ARF) remains high despite advances in supportive care. There are no established effective drug therapies, and dialysis may promote renal injury via hypotension or neutrophil activation. Many agents [e.g., mann...

E-Health for Zero Infections - Facilitating Access to and Use of HIV Pre-Exposure Prophylaxis (PrEP) in The Netherlands
https://clinicaltrials.gov/ct2/show/NCT05093036

Oct 26th, 2021 - Rationale: The population impact of HIV pre-exposure prophylaxis (PrEP) largely depends on the uptake and consistent use of PrEP by people at high risk for HIV infection. In the Dutch National PrEP Programme (NPP), PrEP care consists of quarterly ...

A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer
https://clinicaltrials.gov/ct2/show/NCT01130519

Oct 18th, 2021 - Background Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) is a familial cancer syndrome characterized by a propensity for developing renal cancer, and uterine and cutaneous leiomyomas. The kidney cancer associated with HLRCC is clinically...

Hypoglycemia Prediction Model
https://clinicaltrials.gov/ct2/show/NCT03006510

Oct 8th, 2021 - Our goal for this Learning Healthcare System Demonstration Project is to reduce the rate of inpatient hypoglycemia. Hypoglycemia can result in longer lengths of stay and increased morbidity and mortality (ie falls and cardiovascular or cerebral ev...

see more →

News  292 results

Dr. Kim on Clinical Trial Eligibility Criteria in Lung Cancer
https://www.onclive.com/view/dr-kim-on-clinical-trial-eligibility-criteria-in-lung-cancer

Oct 6th, 2021 - Edward S. Kim, MD, chair, Department of Solid Tumor Oncology, Levine Cancer Institute, discusses clinical trial eligibility criteria in lung cancer. Kim led a task force that evaluated the impact of eligibility criteria on clinical trial enrollme...

Fox Chase Investigates Screening Methods to Avoid Unnecessary Radical Cystectomy
https://www.onclive.com/view/fox-chase-investigates-screening-methods-to-avoid-unnecessary-radical-cystectomy

Oct 6th, 2021 - Alexander Kutikov, MD Chief of the Division of Urology and Urologic Oncology Fox Chase Cancer Center Philadelphia, Pennsylvania Although the standard of care for muscle invasive bladder cancer (MIBC) is to remove the entire bladder, in so...

Enfortumab Vedotin Challenges Standard of Care in Urothelial Carcinoma
https://www.onclive.com/view/enfortumab-vedotin-challenges-standard-of-care-in-urothelial-carcinoma

Oct 5th, 2021 - Two indications have been granted by the FDA to the Nectin-4directed antibody, enfortumab vedotin-ejfv (Padcev), marking a shift in the treatment landscape for patients with advanced urothelial carcinoma. The first, a conversion of an accelerated ...

IV Antibiotic Approved for Kids With Skin Infections
https://www.medpagetoday.com/infectiousdisease/generalinfectiousdisease/93737

Jul 23rd, 2021 - Antibiotic dalbavancin (Dalvance), previously approved to treat bacterial skin infections in adults, received FDA approval for the pediatric population from birth, manufacturer AbbVie said in a press release on Friday. Dalbavancin was described as...

New Mechanism of Action Results Renew Interest in Eribulin
https://www.onclive.com/view/new-mechanism-of-action-findings-renew-interest-in-eribulin

Jul 16th, 2021 - There has been renewed interest in eribulin mesylate (Halaven) following its FDA approval for advanced or unresectable liposarcoma and with the introduction of a growing body of preclinical work suggesting the agent has a novel anti—mesenchymal me...

see more →